Byrne Financial Freedom’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$212K Hold
3,852
0.11% 92
2025
Q1
$272K Buy
3,852
+161
+4% +$11.4K 0.15% 80
2024
Q4
$243K Buy
+3,691
New +$243K 0.11% 87